BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough multiples on tariff-scenario earnings, effectively ...

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently ...

BMO Capital analyst Kostas Biliouris initiated ... Duchenne muscular dystrophy and myotonic dystrophy type 1. The DM1 market is large enough to accommodate multiple players, and Dyne could ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...

Telos (NASDAQ:TLS – Get Free Report) had its target price lowered by analysts at BMO Capital Markets from $4.50 to $3.00 in a research note issued to investors on Tuesday,Benzinga reports.

BMO Capital Markets’ price target suggests a potential upside of 24.89% from the stock’s current price. A number of other brokerages have also issued reports on PTGX.

On Thursday, BMO Capital Markets sustained their Market Perform rating on Casey’s General Stores (NASDAQ:CASY), with a steady price target of $450.00. The convenience store chain, currently valued at ...

BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of $12 ...

On Tuesday, BMO Capital Markets began coverage of Avidity Biosciences (NASDAQ:RNA) shares, assigning an Outperform rating and setting a price target of $72.00. Currently trading at $29.58, the stock ...

Brian Belski of BMO Capital Markets is sticking to his call for the S&P/TSX Composite index (^GSPTSE) to hit 28,500 by the end of 2025. Trump’s 25 per cent across-the-board tariffs on Canadian imports ...